NIH Awards Hesperos Research Grant to Develop Animal-Free Botox Testing Platform

ORLANDO, Fla.--(BUSINESS WIRE)-- #HEAL--Hesperos, a leader in emulating human biology for drug discovery, was awarded a $2 million research grant by the National Center for Advancing Translational Sciences (NCATS) in collaboration with the U.S. Food and Drug Administration (FDA). The goal of the effort is to develop an advanced testing platform capable of assessing the potency of the Botulinum Toxin (BoT) without the need for animal testing. Botulinum Toxin is widely recognized for its clinical efficac